Logotype for Granules India Limited

Granules India (532482) investor relations material

Granules India Q2 25/26 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Granules India Limited
Q2 25/26 earnings summary13 Nov, 2025

Executive summary

  • Achieved 34% year-over-year revenue growth in Q2 FY 2026, led by formulation business in North America and Europe, with EBITDA growth despite a ₹200 million loss from SLS/Ascelis Peptides.

  • Operational efficiency, improved product mix, and capacity expansion contributed to margin improvement.

  • Regulatory remediation at Gagillapur is in final stages, with FDA meeting scheduled for January 2026 and facility cleared by German and Danish authorities.

  • Genome Valley facility received FDA approval, adding 10 billion doses of capacity and enabling new product launches.

  • SLS Peptides (including Senn Chemicals) integration progressing, with profitability targeted for Q4 FY 2026.

Financial highlights

  • Q2 FY 2026 revenue: ₹12,970 million, up 34% year-over-year and 7% sequentially.

  • Gross margin: 65.7%, up 368 bps year-over-year and 82 bps sequentially.

  • EBITDA: ₹2,782 million (21.5% of sales), up 37% year-over-year.

  • PAT increased 34% year-over-year to ₹1,306 million, with PAT margin stable at 10.1%.

  • R&D expenses: ₹705 million (5.4% of sales), consistent with prior quarters.

Outlook and guidance

  • Expecting normalization of operations and new product approvals at Gagillapur post-remediation.

  • Anticipate double-digit top-line growth from FY 2027, supported by capacity expansion and new launches.

  • SLS Peptides expected to turn EBITDA profitable in Q4 FY 2026, with full profitability targeted in FY 2027.

  • R&D investments and regulatory progress support long-term strategic growth.

  • Portfolio expansion and new product launches are expected to drive future growth.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Granules India earnings date

Logotype for Granules India Limited
Q3 25/2623 Jan, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Granules India earnings date

Logotype for Granules India Limited
Q3 25/2623 Jan, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Granules India Limited is a pharmaceutical company engaged in the manufacturing and distribution of active pharmaceutical ingredients (APIs), pharmaceutical formulations intermediates (PFIs), and finished dosage forms (FDFs). The company serves global pharmaceutical markets, supplying essential medicines across therapeutic categories such as pain management, cardiovascular, and anti-infectives. The company operates manufacturing facilities in India and internationally. It is headquartered in Hyderabad, India, and its shares are listed on the BSE.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage